Esther Bouman‐Thio

Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis

Honghui Zhou, Haishan Jang, Roy Fleischmann et al. · The Journal of Clinical Pharmacology · 2007 · 191 citations

Inflammation, Rheumatology, Rheumatoid Disorder +15

Monoclonal antibody-induced cytokine-release syndrome

Peter J. Bugelski, Ram Achuthanandam, Renold J. Capocasale et al. · Expert Review of Clinical Immunology · 2009 · 159 citations

Inflammation, Cytokine, Autoimmune Disease +14

Pharmacokinetics, pharmacodynamics and safety of a human anti‐IL‐6 monoclonal antibody (sirukumab) in healthy subjects in a first‐in‐human study

Zhenhua Xu, Esther Bouman‐Thio, Craig Comisar et al. · British Journal of Clinical Pharmacology · 2011 · 96 citations · Full text

Subcutaneous Bioavailability of Golimumab at 3 Different Injection Sites in Healthy Subjects

Zhenhua Xu, Qingmin Wang, Yanli Zhuang et al. · The Journal of Clinical Pharmacology · 2009 · 93 citations

Healthy Subjects, Sc Golimumab, Subcutaneous Bioavailability +15

First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis

Yanli Zhuang, César A. Calderón, Stanley J. Marciniak et al. · European Journal of Clinical Pharmacology · 2016 · 82 citations

Autoimmune Disease, Healthy Subjects, Medicine +8